Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 8 November 2019, 18:00 HKT/SGT
Share:
    

Source: Holista CollTech Ltd
iGalen and Holista announce resolution with ATM Metabolics

PERTH, AU, Nov 8, 2019 - (ACN Newswire) - Holista, a research-driven biotech company that develops natural ingredient and wellness products, and its distributor iGalen are pleased to announce that they have resolved their disputes with ATM Metabolics and its founder Dr. Joseph Ahrens, a two time Nobel prize nominee and discoverer of Emulin. As a result, they will no longer be carrying Emulin.

If you would like to purchase the product in the future, please contact ATM at www.atmmetabolics.com. We wish ATM and Dr. Ahrens success in their future endeavours, and thank them for working with us to resolve the disputes.

Holista CollTech (ASX:HCT) is a research-driven biotech company. Headquartered in Perth with operations in Malaysia, it is dedicated to delivering first-class natural ingredients and wellness products globally. Holista's ingredients include low-GI baked products, reduced-sodium salts, low-fat fried foods and low calorie sugar. www.holistaco.com.

iGalen markets a range of premium-quality nutritional supplements that are sold directly to Distributors and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Singapore, Mexico, Malaysia, and the Philippines. Visit www.igalen.com.


Nov 8, 2019 18:00 HKT/SGT
Topic: Legal Action
Sectors: BioTech, HealthCare
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Holista CollTech Ltd
Oct 18, 2019 14:45 HKT/SGT
Malaysian Companies Develop Ingredients for World's First Healthy Bubble Tea
Oct 17, 2019 17:00 HKT/SGT
Holista Collaborates to Develop World's First Combined Suite of Healthybubble Tea Ingredients amidst Concerns of Diabetes and Obesity
July 24, 2019 15:00 HKT/SGT
Global BioLife unveils naturally modified Laetose at Harvard Global Catalyst Health Summit
Jan 28, 2019 12:00 HKT/SGT
Global BioLife's 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis
Jan 16, 2019 10:30 HKT/SGT
Two Malaysian Companies to Develop Breakthrough Low GI Roti Canai
Feb 14, 2018 17:00 HKT/SGT
Holista Group Company signs US$6M MOU to supply Low-GI Noodle Mix to Wing's of Canada
Oct 24, 2017 18:00 HKT/SGT
Singapore eDevelopment's Global BioLife develops Low-GI Modified Sugar
Oct 19, 2017 16:00 HKT/SGT
ASX-Listed Holista and Holista Foods Inc. (USA) Develop Breakthrough Noodle Formula with Low-Glycemic Score of 38
Aug 15, 2017 19:00 HKT/SGT
Singapore eDevelopment's Global BioLife and Chemia Corp. to develop 3F suite of Functional Fragrances
May 22, 2017 11:00 HKT/SGT
Singapore eDevelopment Subsidiary Initiates Research on New Universal Drug Platform
More news >>
 News Alerts
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: